Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms.
Osteoporosis is a common skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to fracture. In the past years, twin and family study have shown that this disease recognizes a strong genetic component and that genetic factors play an important role in regulating bone mineral density (BMD). While in few isolate conditions osteoporosis can be inherited in a simple Mendelian pattern, due to single gene mutations, in the majority of cases has to be considered a multifactorial polygenic disease in which genetic determinants are modulated by hormonal, environmental and nutritional factors. Given the important role that steroid hormones play in bone cell development and in the maintenance of normal bone architecture, polymorphisms at receptor of the steroid/thyroid hormone receptor superfamily, such as estrogen receptor alpha (ERalpha) and Vitamin D receptor (VDR) have been thoroughly investigated in the last years and appeared to represent important candidate genes. The individual contribution of these genetic polymorphisms to the pathogenesis of osteoporosis remains to be universally confirmed and an important aim in future work will be to define their functional molecular consequences and how these polymorphisms interact with each other and with the environment to cause the osteoporotic phenotype. A further promising application of genetic studies in osteoporosis comes from their pharmacogenomic implications, with the possibility to give a better guidance for therapeutic agents commonly used to treat this invalidating disorder or to identify target molecules for new therapeutic agents.
Gennari
L
L
Department of Internal Medicine, University of Florence, Viale Pieraccini 6, 50135 Florence, Italy. gennari@unisi.it
Becherini
L
L
Falchetti
A
A
Masi
L
L
Massart
F
F
Brandi
M L
ML
D001842:Bone and Bones / Q000502:physiology; D005938:Glucocorticoids / Q000502:physiology; D012739:Gonadal Steroid Hormones / Q000502:physiology; D006801:Humans; D010024:Osteoporosis / Q000235:genetics*; D011110:Polymorphism, Genetic; D011987:Receptors, Steroid / Q000235:genetics*
D005938:Glucocorticoids; D012739:Gonadal Steroid Hormones; D011987:Receptors, Steroid